The United States Food and Drug Administration (FDA) authorized the sale of a brand of electronic cigarettes from RJ Reynolds on Wednesday because it understands that they can help smokers quit smoking.
Electronic cigarettes for "vaping" have been commercialized and popularized in the United States for more than a decade without regulation by the Government. Now, in compliance with a court ruling, the FDA has given its approval after studying this product.
The agency authorizes the sale of the Vuse brand of electronic cigarettes on the understanding that the benefits of this device for adults who want to give up the traditional cigarette outweigh the risks of addiction among adolescents.
According to the FDA, lYou Vuse help smokers cut down on tobacco use or even quit.
The FDA study concludes that Vuse reduces exposure to toxic chemicals in conventional cigarettes, agency director Mitch Zeller said in a statement.
The Vuse brand offers cigarettes that have the flavor of tobacco, unlike many other brands that offer sweet or fruit flavors and that have become extremely popular with minors who, by law, cannot buy tobacco products.
The FDA and the Centers for Disease Control and Prevention (CDC) released a study last month in which they estimate that more than 2 million schoolchildren have used electronic cigarettes so far this year, and 80% of them consumed products with artificial flavors.
The Vuse Solo, which went on sale in 2013, They consist of a rechargeable metal device in the shape of a conventional cigarette.
The FDA rejected another ten requests from RJ Reynolds for the authorization of products with other flavors, and continues to study an order from that firm for the sale of a formula that contains nicotine and is flavored with mint.
The price of the shares of British American Tobacco – of which RJ Reynolds is a subsidiary – and of other manufacturers of electronic cigarettes rose after the FDA issued its first authorization for the sale of these types of products.